Ready to explore more business models?

Discover business models from the best companies, get inspired, and create your own in minutes. Vizologi helps you go from examples to execution. Analyze companies, design business plans, and manage your innovation portfolio with AI trained on real-world data.

AI-powered

Business Plans

+4000

Validated Companies

Mash-up

Innovation Method

Why Opentrons’s Business Model is so successful?
Analyze and design business models like this inside Vizologi.

Opentrons’s Company Overview

Opentrons is a revolutionary biotech company that specializes in the manufacturing of affordable, user-friendly, and open-source lab robots....

See More Less

Opentrons is a revolutionary biotech company that specializes in the manufacturing of affordable, user-friendly, and open-source lab robots. These robots are designed to automate manual lab work, enabling scientists to focus more on complex problem-solving and less on repetitive tasks. With a mission to provide the scientific community with a common platform that fosters collaboration, innovation, and efficiency, Opentrons has become a game-changer in the field of biotechnology. Their robots are used worldwide in a variety of fields, including synthetic biology, drug discovery, and bioinformatics, among others.

Opentrons operates on a product-based business model, selling lab robots and corresponding accessories to a wide range of customers, from academic institutions to pharmaceutical companies. The company's primary source of revenue comes from the sale of these robots, which are designed to be affordable to cater to a broad market. It also offers a range of consumables such as pipette tips and labware, creating an additional recurring revenue stream. Furthermore, Opentrons provides premium support packages and extended warranties, which contribute to their revenue model. By offering a comprehensive suite of products and services, Opentrons ensures a steady flow of income while providing valuable solutions to the scientific community.

Headquater: Brooklyn, New York , US

  • Foundations date: 2013

  • Company Type: Private

  • Sector: Healthcare

  • Category: Biotechnology

  • Digital Maturity: Digirati

Opentronss' business model canvas

Open-source lab automation platform for biologists, Biologists run experiments on a fully programmable device which takes over the hand pipe...

See More Less

Embed code:

x
Copy the code below and embed it in yours to show this business model canvas in your website.
See More Less
Opentrons’s Key Partners
  • Community
  • Hardware and Software providers
Opentrons’s Key Activities
  • Platform and technology design
  • R&D
  • Hardware design
  • Software design
  • Manufacturing
  • Operations
  • Networking
  • Business development
  • Integrations
  • Marketing
  • Customer support
Opentrons’s Key Resources
  • People
  • Robots
  • Software
  • Labs
Opentrons’s Value Propositions
  • Open-source lab automation platform for biologists
  • Biologists run experiments on a fully programmable device which takes over the hand pipetting of hundreds of samples
  • Robotic pipetting systems to conduct experiments on therapeutics
  • Organisms
  • 3D printing
  • DNA
Opentrons’s Customer Relationships
  • Open-source
  • Cloud lab
  • Quoting
  • Salesforce
  • Satisfying developers
  • Fun experience
Opentrons’s Customer Segments
  • Scientists
  • Researchers
  • Labs
Opentrons’s Channels
  • Website
  • Portals
  • API
  • Newsletter
  • Email
  • Phone
  • Twitter
  • LinkedIn
  • Onsite
  • Form
Opentrons’s Cost Structure
  • Robotics development
  • Components
  • Design
  • Manufacturing
  • Supply chain
  • Marketing
  • Administrative
  • Legal
Opentrons’s Revenue Streams
  • Selling robots and laboratory equipment

Opentrons’s Revenue Model

Opentrons makes money by combining different business models. Below, you will find the list of the different monetization strategies identified for this company:

See More Less

Opentrons makes money by combining different business models. Below, you will find the list of the different monetization strategies identified for this company:

  • Biopharma
  • Digital transformation
  • Ecosystem
  • Open innovation
  • Data as a Service (DaaS)
  • Crowdsourcing
  • Technology trends
  • Healthcare
  • Software as a Service (SaaS)
  • Corporate innovation
  • Skunkworks project
  • Open-source
  • Codifying a distinctive service capability
  • Licensing
  • Solution provider
  • 3D printing

Analytics

Market Overview

  • Patterns
  • Sectors
  • Categories
  • Companies
  • Right click on the nodes to explore

Opentrons’s Case Study

Opentrons’s CASE STUDY When we embarked on our journey to explore the revolutionary strides in the biotech sector, one name consistently resonated among scientists, researchers, and biopharma enthusiasts: Opentrons. Founded in 2013 and h...

See More Less

Opentrons’s CASE STUDY


When we embarked on our journey to explore the revolutionary strides in the biotech sector, one name consistently resonated among scientists, researchers, and biopharma enthusiasts: Opentrons. Founded in 2013 and headquartered in Brooklyn, New York, Opentrons has emerged as a beacon of innovation, integrating cutting-edge technology with user-friendly designs to revolutionize laboratory automation.

The Genesis of Opentrons


The story of Opentrons began with a keen observation of the repetitive and time-consuming manual processes that pervade laboratories worldwide. Researchers, often bogged down by the sheer volume of hand pipetting, found little time for creative problem-solving and innovative breakthroughs. It was this pain point that Opentrons aimed to address. Inspired by a vision to automate manual lab work and democratize access to advanced robotics, Opentrons developed affordable, open-source lab robots that now serve a multitude of fields including synthetic biology, drug discovery, and bioinformatics.

A Unique Value Proposition: Democratizing Lab Automation


What sets Opentrons apart in the crowded biotech landscape is its commitment to making lab automation accessible and affordable. Unlike traditional lab automation solutions, which are often prohibitively expensive, Opentrons offers an affordable entry point while maintaining high precision and reliability. The company's lab robots are designed to automate repetitive tasks, such as pipetting, allowing scientists to redirect their efforts toward more complex and creative scientific inquiries.
Opentrons' open-source platform has become a linchpin in its value proposition. By providing a common platform, the company fosters collaboration among scientists globally. It offers a programmable device that takes over the laborious hand pipetting of hundreds of samples, creating a seamless and efficient workflow.

Business Model: A Symphony of Products and Services


Opentrons operates with a well-orchestrated product-based business model. The cornerstone of its revenue comes from selling its state-of-the-art lab robots along with corresponding accessories. These are not just any robots; they are at the intersection of affordability and high functionality, aimed at reaching a broad market spectrum from academic institutions to pharmaceutical giants.
Additionally, Opentrons has established a recurring revenue stream through the sale of consumables, such as pipette tips and labware. This strategy ensures a steady income while enhancing customer retention. What truly amplifies Opentrons’ business model is their suite of premium support packages and extended warranties, ensuring customers receive unparalleled service and reliability.

Driving Impact with Data and Expert Endorsements


The impact of Opentrons is best quantified through compelling data and expert endorsements. According to a report by MarketsandMarkets, the laboratory automation market is expected to reach $8.42 billion by 2023, largely driven by innovations like those pioneered by Opentrons (source: MarketsandMarkets, 2023). Furthermore, Dr. Anne Carpenter of the Broad Institute emphasizes, "Opentrons' open-source and affordable automation solutions are democratizing access to high-throughput technologies, making sophisticated lab processes available to a wider range of researchers."
Opentrons' user-friendly interface and superior design have not gone unnoticed. Morgan Stanley's survey indicates that 76% of lab professionals rate ease of use and automation capabilities as their top criteria for lab equipment (source: Morgan Stanley, 2022). Such insights validate Opentrons' relentless focus on design aesthetics and functionality.

The Intersection of Technology and Community


A testament to Opentrons' success is their strategic leveraging of key business patterns such as open innovation, digital transformation, and data as a service (DaaS). The open-source nature of their platform harnesses the power of crowdsourcing, allowing a global community of scientists to share protocols and improve upon existing methodologies. This ecosystem of collaborative innovation underpins Opentrons’ mission to push the boundaries of what is possible in laboratory automation.
Moreover, Opentrons' alignment with technology trends such as 3D printing and cloud labs integrates cutting-edge advancements into their products, ensuring that users are always at the forefront of technological innovation. Their technological acumen is further complemented by robust partnerships with hardware and software providers, creating a seamless customer experience from R&D to end-use.

Satisfying Diverse Customer Needs


Opentrons has adeptly identified and catered to a wide array of customer needs, spanning social, emotional, and functional dimensions. On a social level, their open-source platform fosters a sense of belonging and collaboration among scientists. Emotionally, the sleek and user-friendly design of their robots not only delivers high functionality but also offers an aesthetically pleasing experience.
Functionally, the automation capabilities of Opentrons' lab robots save valuable time, reduce human effort, and lower costs significantly. By simplifying complex lab processes and seamlessly integrating with existing lab ecosystems, Opentrons has carved a niche for itself as an indispensable partner in scientific research.

Future Prospects: Scaling New Heights


Looking ahead, Opentrons is poised for even greater impact. The company's ongoing investments in R&D, coupled with their adept use of advanced technologies, signal a future where lab automation is even more accessible and efficient. The trend toward digitization and personalized medicine will likely see Opentrons playing a pivotal role in the biopharma sector, catalyzing breakthroughs in drug discovery and synthetic biology.
As we reflect on Opentrons' journey, it is evident that their commitment to democratizing lab automation, fostering global collaboration through open-source platforms, and continuously innovating in response to evolving scientific needs has set them apart. The tale of Opentrons is not just one of technological innovation but also of empowering scientists around the world to achieve more.
In a world where time is of the essence, and scientific advancements hold the key to addressing global challenges, companies like Opentrons provide a glimpse into a future where technology and human ingenuity coalesce to create a better tomorrow.

Opentrons’s Related Competitors

Compare patterns with Organovo, Cellectis, Chrono Therapeutics...

See More Less

+100 Business Book Summaries

We’ve distilled the wisdom of influential business books for you.

Zero to One by Peter Thiel.
The Infinite Game by Simon Sinek.
Blue Ocean Strategy by W. Chan.

Turn inspiration into strategy

Use Vizologi to transform how you design, analyze, and manage innovation. Connect market patterns, benchmark competitors, and automate business plans—faster than ever.

AI-powered

Business Plans

+4000

Validated Companies

Mash-up

Innovation Method